Mark Engelman

Mark Engelman qualified as a pharmacologist (Kings College London) converted to law, (City University), qualified at The Bar, (Inns of Court School of Law), was appointed Master of The Honourable Society of Gray’s Inn and Associate Professor at Notre Dame University London Gateway. Mark practices as a specialist Intellectual Property Barrister at 4-5 Gray’s Inn, London, is a visiting professor to Brunel University and indue course Oxford University and Cambridge University. He has published Engelman’s Intellectual Property Update (Bloomsbury, 2005) and been commissioned to write numerous  academic papers within the field of intellectual property, including in TMA Review and Chartered Institute of Patents Agents Journal. He has sat on the boards of numerous companies including Gucci’s Alexander McQueen and currently sits on The Development Council of The Globe Theatre London.

Mark joined the VHI as a Research Associate in 2015 to explore the relationship between ethics and Intellectual Property (IP) law with an emphasis on the commonality of reasoning between commercial branding and religious symbolism.

He has been standing counsel to Apple, Inc, Specsavers, and acting in numerous high profile legal actions including the lead case on trade mark dilution in the Court of Justice of the European Union.His key cases include 'The Christian Science Board of Directors of The First Church of Christ, Scientist v Office For The Harmonisation of The Internal Market' (Court of First Instance of the European Union). He has also spoken and/or chaired over 60 international conferences including: Transfer Pricing and Intangible Properties (26 May 2006, European Commission); European Union Training Mission, Training the Judges Magistrates and Public Prosecutors on Intellectual Property Enforcement (Bucharest, Romania, 9-13 March 2008); Teaching the Taxing Authorities Intellectual Property (European Commission, Prague, May 2010); Moot Judge of the Pentonville Prison Debate between Oxford University and the Inmates (Judge, 23 July 2013); The Claim to Damages and Other Final Remedies (University College London, Intellectual Property Masterclass, 8 March 2013); and the VHI’s Patents on Life Conference in Sept. 2015 (on Copyright Protection of Gene Sequences).